Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 15 8:40 PM | ERIC DUBE | Proposed Sale | 243,735 | $53.27 | $13.0M | — | View → |
| Sep 16, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Sale | 112,850 | $63.33 | $7.1M | 98,197(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Sale | 96,198 | $62.25 | $6.0M | 98,197(D) | View → |
| Sep 17, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Sale | 8,282 | $65.07 | $538.9K | 117,066(D) | View → |
| Sep 16, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Sale | 172,717 | $63.43 | $11.0M | 117,066(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Sale | 102,190 | $62.26 | $6.4M | 117,066(D) | View → |
| Sep 15, 2026 | Sep 18 1:33 AM | Jula InrigEVP, Head of R&D & CMO | Sale | 44,674 | $62.34 | $2.8M | 100,491(D) | View → |
| Sep 15, 2026 | Sep 18 1:32 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 37,500 | $62.34 | $2.3M | 105,389(D) | View → |
| Sep 17, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 108,493 | $64.61 | $7.0M | 432,886(D) | View → |
| Sep 16, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 195,841 | $63.45 | $12.4M | 432,886(D) | View → |
| Sep 15, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 95,666 | $62.26 | $6.0M | 432,886(D) | View → |
| Sep 15, 2026 | Sep 18 1:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 50,508 | $62.34 | $3.1M | 87,508(D) | View → |
| Sep 15, 2026 | Sep 18 1:29 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 5,375 | $62.33 | $335.0K | 42,353(D) | View → |
| Sep 17, 2026 | Sep 17 8:35 PM | ERIC DUBE | Proposed Sale | 108,493 | $63.48 | $6.9M | — | View → |
| Sep 17, 2026 | Sep 17 8:30 PM | PETER HEERMA | Proposed Sale | 8,282 | $63.48 | $525.7K | — | View → |
| Sep 16, 2026 | Sep 16 8:33 PM | WILLIAM ROTE | Proposed Sale | 112,850 | $62.51 | $7.1M | — | View → |
| Sep 16, 2026 | Sep 16 8:32 PM | PETER HEERMA | Proposed Sale | 172,717 | $62.51 | $10.8M | — | View → |
| Sep 16, 2026 | Sep 16 8:30 PM | ERIC DUBE | Proposed Sale | 195,841 | $62.51 | $12.2M | — | View → |
| Sep 15, 2026 | Sep 15 8:44 PM | SANDRA CALVIN | Proposed Sale | 5,375 | $65.79 | $353.6K | — | View → |
| Sep 15, 2026 | Sep 15 8:44 PM | CHRISTOPHER CLINE | Proposed Sale | 50,508 | $65.79 | $3.3M | — | View → |
Page 1 of 10
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 9:00 PM | John A OrwinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Meckler Jeffrey ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | LYONS GARY ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Timothy CoughlinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Suzanne Louise BruhnDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Roy D. BaynesDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |